CoChat

Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis

Open access
van der Straten, A. L., Denys, D., van Wingen, G. A. · 2017 · Scientific Reports
Cited by 44

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Neurobiological models of obsessive-compulsive disorder (OCD) posit that its clinical symptoms such as repetitive thoughts and behaviors are related to hyperactivity in the cortico–striato–thalamo–cortical (CSTC) circuit. Small scale neuroimaging studies have shown that treatment of OCD is associated with reduced activity across different brain structures within this circuitry. We performed the first meta-analysis of positron emission tomography (PET) and single photon emission computed tomography (SPECT) studies that investigated cerebral blood flow or glucose metabolism in patients with OCD before and after pharmacological or psychological treatment. We calculated standardized mean differences for the regions-of-interest most often reported. The meta-analysis revealed small reductions in activity in the caudate nucleus and orbitofrontal cortex after treatment with a serotonin reuptake inhibitor or cognitive behavioral therapy. Small reductions were also observed in the thalamus when one SPECT study with a large opposite effect was excluded from the analysis. Meta-regression analyses for the caudate nucleus showed no significant effect of the type of treatment, decrease in symptom severity, mean duration until the follow-up scan, or year of publication. These results show that pharmacological and psychological treatments reduce resting CSTC circuit activity, and provide further support for the CSTC circuit model in OCD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-17593-7

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 33

  1. Benkelfat, C. et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry 47, 840–848 (1990). · DOI · Paper page
  2. Schwartz, J. M. et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53, 109–113 (1996). · DOI · Paper page
  3. Hansen, E. S., Hasselbalch, S., Law, I. & Bolwig, T. G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol 5, 1–10, https://doi.org/10.1017/S1461145701002681 (2002). · DOI · Paper page
  4. Swedo, S. E. et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49, 690–694 (1992). · DOI · Paper page
  5. Perani, D. et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. The British journal of psychiatry: the journal of mental science 166, 244–250 (1995). · DOI · Paper page
  6. Saxena, S. et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59, 250–261 (2002). · DOI · Paper page
  7. Apostolova, I. et al. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res 184, 105–116, https://doi.org/10.1016/j.pscychresns.2010.08.012 (2010). · DOI
  8. Yamanishi, T. et al. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Res 172, 242–250, https://doi.org/10.1016/j.pscychresns.2008.07.004 (2009). · DOI
  9. Nakatani, E. et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 124, 113–120 (2003). · DOI
  10. Ho Pian, K. L. et al. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res 138, 89–97, https://doi.org/10.1016/j.pscychresns.2004.12.003 (2005). · DOI
  11. Hoehn-Saric, R., Pearlson, G. D., Harris, G. J., Machlin, S. R. & Camargo, E. E. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 148, 1243–1245, https://doi.org/10.1176/ajp.148.9.1243 (1991). · DOI · Paper page
  12. Rubin, R. T., Ananth, J., Villanueva-Meyer, J., Trajmar, P. G. & Mena, I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 38, 429–437 (1995). · DOI
  13. Karadag, F. et al. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder. Psychiatry Res 213, 169–177, https://doi.org/10.1016/j.pscychresns.2012.07.005 (2013). · DOI
  14. Hedges, L. V. & Olkin, I. Statistical methods for meta-analysis (Academic Press, 1985).
  15. Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Routledge Academic, 1988).
  16. Holm, S. A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics 6, 65–70 (1979).
  17. Deutsch, G., Mountz, J. M., Katholi, C. R., Liu, H. G. & Harrell, L. E. Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38, 6–13 (1997).
  18. Holcomb, H. H. et al. PET-FDG test-retest reliability during a visual discrimination task in schizophrenia. J Comput Assist Tomogr 17, 704–709 (1993). · DOI
  19. Bartlett, E. J. et al. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8, 502–512, https://doi.org/10.1038/jcbfm.1988.91 (1988). · DOI · Paper page
  20. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557–560, https://doi.org/10.1136/bmj.327.7414.557 (2003). · DOI · Paper page
  21. Aylward, E. H. et al. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiat 53, 577–584 (1996). · DOI · Paper page
  22. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997). · DOI · Paper page
  23. Berkey, C. S., Hoaglin, D. C., Mosteller, F. & Colditz, G. A. A random-effects regression model for meta-analysis. Stat Med 14, 395–411 (1995). · DOI · Paper page
  24. Thompson, S. G. & Higgins, J. P. How should meta-regression analyses be undertaken and interpreted? Stat Med 21, 1559–1573, https://doi.org/10.1002/sim.1187 (2002). · DOI · Paper page
  25. Kang, D. H. et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 107, 291–297 (2003). · DOI · Paper page
  26. Hendler, T. et al. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD. Psychiatry Res 124, 87–103 (2003). · DOI
  27. Carey, P. D. et al. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry 4, 30, https://doi.org/10.1186/1471-244X-4-30 (2004). · DOI · Paper page
  28. Molina, V. et al. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 36, 2234–2238 (1995).
  29. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097, https://doi.org/10.1371/journal.pmed.1000097 (2009). · DOI · Paper page
  30. Saxena, S. et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry 14, 197–205, https://doi.org/10.1038/sj.mp.4002134 (2009). · DOI · Paper page
  31. Ginsberg, M. D. et al. Increases in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol 23, 152–160, https://doi.org/10.1002/ana.410230208 (1988). · DOI · Paper page
  32. Conca, A. et al. Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety. Psychiatry Res 98, 43–54 (2000). · DOI
  33. Dunn, R. T. et al. Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Res 140, 181–198, https://doi.org/10.1016/j.pscychresns.2005.07.005 (2005). · DOI

Cited by

See all 44

Metadata

Authors
van der Straten, A. L., Denys, D., & van Wingen, G. A.
Venue
Scientific Reports
Published
2017-12-12
Volume
7
Issue
1
Pages
17464-17464
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2774876719
Cited by
44
References
12
FWCI
0.97
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-017-17593-7
The paper
van der Straten, A. L., Denys, D., & van Wingen, G. A. (2017). Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-017-17593-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.